IVA
Price
$3.56
Change
+$0.10 (+2.89%)
Updated
Oct 2 closing price
Capitalization
794.23M
51 days until earnings call
Intraday BUY SELL Signals
NKTX
Price
$2.58
Change
+$0.02 (+0.78%)
Updated
Oct 2 closing price
Capitalization
191.24M
39 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IVA vs NKTX

IVA vs NKTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IVA vs. NKTX commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVA is a Buy and NKTX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
IVA vs NKTX: Fundamental Ratings
IVA
NKTX
OUTLOOK RATING
1..100
6383
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
10
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
8657
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NKTX's Valuation (10) in the null industry is significantly better than the same rating for IVA (95). This means that NKTX’s stock grew significantly faster than IVA’s over the last 12 months.

NKTX's Profit vs Risk Rating (100) in the null industry is in the same range as IVA (100). This means that NKTX’s stock grew similarly to IVA’s over the last 12 months.

NKTX's SMR Rating (97) in the null industry is in the same range as IVA (100). This means that NKTX’s stock grew similarly to IVA’s over the last 12 months.

NKTX's Price Growth Rating (57) in the null industry is in the same range as IVA (86). This means that NKTX’s stock grew similarly to IVA’s over the last 12 months.

NKTX's P/E Growth Rating (100) in the null industry is in the same range as IVA (100). This means that NKTX’s stock grew similarly to IVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IVANKTX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 6 days ago
76%
Bullish Trend 12 days ago
85%
Declines
ODDS (%)
Bearish Trend 10 days ago
84%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (IVA: $3.56 vs. NKTX: $2.58)
Brand notoriety: IVA and NKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IVA: 283% vs. NKTX: 60%
Market capitalization -- IVA: $794.23M vs. NKTX: $191.24M
IVA [@Biotechnology] is valued at $794.23M. NKTX’s [@Biotechnology] market capitalization is $191.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IVA’s FA Score shows that 0 FA rating(s) are green while NKTX’s FA Score has 1 green FA rating(s).

  • IVA’s FA Score: 0 green, 5 red.
  • NKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, NKTX is a better buy in the long-term than IVA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IVA’s TA Score shows that 5 TA indicator(s) are bullish while NKTX’s TA Score has 5 bullish TA indicator(s).

  • IVA’s TA Score: 5 bullish, 5 bearish.
  • NKTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both IVA and NKTX are a good buy in the short-term.

Price Growth

IVA (@Biotechnology) experienced а +5.64% price change this week, while NKTX (@Biotechnology) price change was -6.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.69%. For the same industry, the average monthly price growth was -14.41%, and the average quarterly price growth was -1.73%.

Reported Earning Dates

IVA is expected to report earnings on Nov 23, 2026.

NKTX is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
IVA
Daily Signal:
Gain/Loss:
NKTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIB1.640.12
+7.89%
AIB Data Centers Inc
GH177.803.05
+1.75%
Guardant Health
CASS54.060.36
+0.67%
Cass Information Systems
COCO55.97-1.04
-1.82%
Vita Coco Company (The)
TKLF1.44-0.05
-3.36%
Tokyo Lifestyle Co Ltd

IVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IVA has been loosely correlated with ABEO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if IVA jumps, then ABEO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVA
1D Price
Change %
IVA100%
+2.89%
ABEO - IVA
38%
Loosely correlated
+0.40%
TVGN - IVA
37%
Loosely correlated
+1.23%
NKTX - IVA
36%
Loosely correlated
+0.59%
CABA - IVA
35%
Loosely correlated
+5.82%
SLDB - IVA
34%
Loosely correlated
-1.86%
More

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with EDIT. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
+0.59%
EDIT - NKTX
53%
Loosely correlated
+3.97%
PRME - NKTX
50%
Loosely correlated
-0.33%
RCKT - NKTX
49%
Loosely correlated
-1.16%
PROK - NKTX
48%
Loosely correlated
+0.58%
RXRX - NKTX
47%
Loosely correlated
+1.23%
More